The former Turing Pharma CEO, now out on bail and awaiting trial for alleged securities fraud, will discuss "the impact of the public eye on pricing practices by life sciences companies," among other topics.
August 16, 2016 at 02:28 PM
1 minute read
UPDATE: 8/17/16, 4:22 p.m. PDT. Martin Shkreli has been canceled as a speaker at the conference.
A life sciences symposium organized by Dorsey & Whitney will include an unusual guest: Martin Shkreli, the indicted pharmaceutical company CEO who gained notoriety last fall for massively increasing the price of a lifesaving AIDS drug.
Presented by BigVoodoo
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
